Lantheus Announces Presentation Featuring PYLARIFY® (Pi

NORTH BILLERICA, Mass., Feb. 10, 2022 -- Lantheus Holdings, Inc. , an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and... | February 10, 2022

Related Keywords

United States , New Jersey , Massachusetts , North Billerica , Sweden , Maryland , Canada , San Francisco , California , American , Michael Gorin , Mark Kinarney , Bausch Health Companies Inc , Lantheus Medical Imaging Inc , Progenics Pharmaceuticals Inc , Corporate Communications , Lantheus Holdings Inc , Urology Associates , Clinical Oncology Genitourinary , Poster Session , Prostate Cancer , Standardized Uptake Value , Results Stratified , Gleason Score , Full Prescribing , Lantheus Holdings , Lantheus Medical Imaging , Progenics Pharmaceuticals , Find Fight , Perflutren Lipid Microsphere , Injectable Suspension , Bausch Health Companies , Nc Stock Exchange , News , Information , Press Release , North , 022 , Lantheus , N , Stablished , Leader , End , Bully , Ntegrated , Provider , Ommitted , O , Nnovative , Maging , Argeted , Herapeutics Lnth Us5165441032 ,